Abbott Laboratories (ABT) Other Non-Current Assets (2009 - 2018)

Abbott Laboratories has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $17.0 million for Q4 2018.

• In Q4 2018, Other Non-Current Assets fell 90.34% year-over-year to $17.0 million; the TTM figure through Dec 2018 stood at $17.0 million (down 90.34% YoY), while the FY2018 annual figure was $17.0 million, down 90.34% from the prior year.
• Other Non-Current Assets came in at $17.0 million for Q4 2018 at Abbott Laboratories, down from $19.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.3 billion in Q4 2014 to a low of $17.0 million in Q4 2018.
• Average Other Non-Current Assets over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2015.
• Year-over-year, Other Non-Current Assets surged 2521.9% in 2016 and tumbled 97.95% in 2017.
• Over 5 years, Other Non-Current Assets stood at $3.3 billion in 2014, then sank by 96.81% to $105.0 million in 2015, then surged by 2521.9% to $2.8 billion in 2016, then sank by 93.61% to $176.0 million in 2017, then tumbled by 90.34% to $17.0 million in 2018.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $17.0 million in Q4 2018, $19.0 million in Q3 2018, and $121.0 million in Q2 2018.